Date:9/24/2009

,392,639 $1,337,682 Short-term bank loans 1,399,075 1,393,345 VAT taxes payable 458,930 277,090 Income taxes payable 490,514 341,214 Other taxes payable 11,890 39,939 Dividends payable 325,417 378,545 Other current liabilities 307,934 142,733 Total current liabilities 4,386,399 3,910,548 Total liabilities 4,386,399 3,910,548 Stockholders' equity: Common stock, $0.001 par value, 50,000,000 shares authorized, 17,908,912 and 14,738,450 shares issued and outstanding at June 30, 2009 and 2008, respectively 17,909 14,739 Series A convertible preferred stock, $0.001 par value, 7,146,500 and 9,384,375 shares issued and outstanding at June 30, 2009 and 2008, respectively 7,147 9,384 Additional paid-in capital 19,694,514 18,002,439 Statutory reserve 2,299,807 1,380,806 Treasury stock (111,587) -- Retained earnings 16,486,775 10,963,131 Accumulated other comprehensive income 2,551,380 2,477,874 Total stockholders' equity 40,945,945 32,848,373 Total liabilities and stockholders' equity $45,322,344 $36,758,921

Consolidated Statements of Operations and Comprehensive Income

                                                   For the Years Ended June 30,
                                                        2009  
'/>"/>
SOURCE  Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
6. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
7. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
8. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
9. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
10. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
11. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders